Targeted therapy of ovarian cancer including immune check point inhibitor.

Korean J Intern Med · 2017 · PMC5583460 · PMID 28823141

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

There was also a strong trend towards an OS advantage, although this was not statistically significant (34.9 months vs. 31.9 months, respectively).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.